Oncogenic gain-of-function EZH2 mutations alter gene–promoter interactions and lead to silencing 1,034 of genes within topologically associating domains, thus resulting in inactivation of multiple tumor-suppressor genes.
- Maria C. Donaldson-Collier
- Stephanie Sungalee
- Elisa Oricchio
